People
Shailesh Pednekar appointed COO – International Business at Bharat Serums and Vaccines
With more than two decades of experience in the pharmaceutical industry, he brings extensive expertise in international business development, commercial strategy, market expansion, and global operation
With more than two decades of experience in the pharmaceutical industry, he brings extensive expertise in international business development, commercial strategy, market expansion, and global operations
Shailesh Pednekar has been appointed as Chief Operating Officer – International Business at Bharat Serums and Vaccines Limited (BSV), a Mankind Group company
In his new role, Pednekar will spearhead BSV’s international business operations, driving global growth strategy, strengthening market presence, and expanding the company’s footprint across key international markets
With more than two decades of experience in the pharmaceutical industry, he brings extensive expertise in international business development, commercial strategy, market expansion, and global operations
Prior to joining BSV, Pednekar held senior leadership positions at Macleods Pharmaceuticals, Hetero Drugs, Ranbaxy, and Cipla, where he played a pivotal role in building and expanding international businesses across multiple geographies
His appointment reflects BSV’s continued focus on accelerating its global growth ambitions and strengthening its presence in international pharmaceutical markets
- Shailesh Pednekar
- BSV
- Vaccines
Upcoming E-conference
Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma
July 17, 2026Register Now
Other Related stories
Divya Dhankhar joins Gilead Sciences as Director – Global Digital Innovation & AI
Dr. Srinivasa Rao Damma appointed General Manager at Vimta Labs
Merck names Miguel Alcalde to lead global commercial strategy; Monia Vial to head North America
View More
Interviews
Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head – API Regulatory Sciences, Biocon Limited
Rising pharma demand driving our India market strategy: Sanjeev Kumar Khandelwal, Head of Division, Characterization Division, Anton Paar India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
View More
Appointments
Divya Dhankhar joins Gilead Sciences as Director – Global Digital Innovation & AI
Dr. Srinivasa Rao Damma appointed General Manager at Vimta Labs
Merck names Miguel Alcalde to lead global commercial strategy; Monia Vial to head North America
View More
Startup
SuperLiving raises $7 million in Series A to scale AI-powered preventive health platform
Lumos Health opens applications for second cohort of HealthTech and MedTech startups
Hoola Health raises $5 million to expand child-centric paediatric care
View More
Digitization
Govt includes vaccines, antimicrobials, NDPS and anti-cancer drugs under QR code authentication
AI moves from experimentation to enterprise tool across pharma value chain: GlobalData
SwishX selected for Anthropic-AWS Agentic AI Accelerator 2026
View More
Upcoming E-conference
July 17, 2026
Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma
Latest Stories
Shailesh Pednekar appointed COO – International Business at Bharat Serums and Vaccines
Merck consolidates India tech operations under new Bengaluru GCC
ZeeLab Pharmacy launches iOS app to expand affordable digital healthcare access
Ambient clinical intelligence is reshaping future of healthcare delivery: Rustom Lawyer, Co-Founder & CEO, Augnito
EuroKids partners with Kauvery Hospitals to promote child health and early development
White Papers
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
Opinion
Ambient clinical intelligence is reshaping future of healthcare delivery: Rustom Lawyer, Co-Founder & CEO, Augnito
NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
Interviews
Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head – API Regulatory Sciences, Biocon Limited
Rising pharma demand driving our India market strategy: Sanjeev Kumar Khandelwal, Head of Division, Characterization Division, Anton Paar India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay VyasPresident and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International
